https://doi.org/10.4081/aiua.2026.15595
Atypical urothelial cells investigation with automated urinalysis and expert review of microscopic sediment as early parameter for suspected bladder cancer patients
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 26 June 2026
Introduction and objectives: Automated urinalysis offers rapid and efficient evaluation of urine sediment; however, most systems do not routinely report epithelial cell atypia. This study aimed to evaluate the clinical relevance of the atypical cell (Atyp.C) parameter generated by the Sysmex UF-4000 analyzer as an early indicator of suspected urothelial carcinoma.
Materials and methods: A prospective study was conducted using the UF-4000 analyzer to detect Atyp.C in urine specimens from high-risk patients. Atyp.C results were collected simultaneously for all samples. Specimens with positive Atyp.C findings underwent urinary tract cytology, which was independently reviewed by board-certified cytopathologists and categorized into four diagnostic groups. Statistical analyses were performed using IBM SPSS version 21.
Results: Among 332 specimens, 20 samples (6.02%) showed Atyp.C values > 0.0/μL. The mean Atyp.C value was 0.6/μL (95% CI 0.064-1.135) in males and 1.20/μL (95% CI 0.608- 1.791) in females, with no significant difference between sexes (p = 0.2549). Of the 20 Atyp.C-positive samples, 5 (25%) demonstrated abnormal cytology, including 2 cases of atypical urothelial cells, 1 case suspicious for high-grade malignancy, and 2 cases of confirmed high-grade urothelial carcinoma. Atyp.C values were significantly higher in abnormal compared with benign cytology (p < 0.01).
Conclusions: The Atyp.C parameter may have potential as an adjunctive screening marker for urothelial abnormalities; however, further validation studies are required.
Downloads
1. Oyaert M, Delanghe J. Progress in Automated Urinalysis. Ann Lab Med. 2019; 39:15-22. DOI: https://doi.org/10.3343/alm.2019.39.1.15
2. Miyazaki J, Nishiyama H. Epidemiology of urothelial carcinoma. Int J Urol 2017; 24:730-734. DOI: https://doi.org/10.1111/iju.13376
3. Fogazzi GB, Pallotti F, Garigali G. Atypical/malignant urothelial cells in routine urinary sediment: worth knowing and reporting. Clin Chim Acta. 2015; 439:107-11. DOI: https://doi.org/10.1016/j.cca.2014.10.021
4. Aydin O. Atypical cells parameter in Sysmex UN automated urine analyzer: feedback from the field. Diagn Pathol. 2021; 16:9. DOI: https://doi.org/10.1186/s13000-021-01068-5
5. Barnes PW, McFadden SL, Machin SJ, Simson E; international consensus group for hematology. The international consensus group for hematology review: suggested criteria for action following automated CBC and WBC differential analysis. Lab Hematol. 2005; 11:83-90. DOI: https://doi.org/10.1532/LH96.05019
6. Aydin O. Atypical cells parameter in an automated urine analyzer: Does it have a future? Anal Biochem. 2020; 600:113763. DOI: https://doi.org/10.1016/j.ab.2020.113763
7. Shukuya K, Morita Y, Hisasue T, et al. Comparison of the clinical performance of the Atyp.C parameter of the UF-5000 fully automated urine particle analyzer with that of microscopic urine sediment analysis. Pract Lab Med. 2023; 36:e00328. DOI: https://doi.org/10.1016/j.plabm.2023.e00328
8. Anderlini R, Manieri G, Lucchi C, et al. Automated urinalysis with expert review for incidental identification of atypical urothelial cells: An anticipated bladder carcinoma diagnosis. Clin Chim Acta. 2015; 451(Pt B):252-256. DOI: https://doi.org/10.1016/j.cca.2015.10.005
9. Barkan GA, Wojcik EM, Nayar R, et al. The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology. Adv Anat Pathol. 2016; 23:193-201. DOI: https://doi.org/10.1097/PAP.0000000000000118
10. Xing J, Reynolds JP. Diagnostic Advances in Urine Cytology. Surg Pathol Clin. 2018; 11:601-610. DOI: https://doi.org/10.1016/j.path.2018.06.001
11. Willner J, Matloob A, Colanta A, Khader SN. Educational Case: Urothelial Carcinoma: An Overview of Pathologic Diagnosis. Acad Pathol. 2020; 7:2374289520958172. DOI: https://doi.org/10.1177/2374289520958172
Ethics Approval
CRediT authorship contribution
DEP contributed to study conception and design, data analysis, statistical analysis, and manuscript drafting; KPS contributed to study conception and design, study supervision, and critical revision of the manuscript; BD contributed to data collection, study supervision, and critical revision of the manuscript; FKD contributed to data collection and manuscript drafting; HS contributed to cytopathological analysis and critical revision of the manuscript; KWA contributed to cytopathological analysis and critical revision of the manuscript. All authors read and approved the final manuscript and agree to be accountable for all aspects of the work.
Supporting Agencies
Data Availability Statement
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.